Medline Inc. (MDLN) vs West Pharmaceutical Services, Inc. (WST)

A side-by-side comparison of Medline Inc. and West Pharmaceutical Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 20, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total returnMDLN vs WST

growth of $100 · dividends reinvested · last 1y
MDLN -17.3% (-17.3%/yr)WST +32.9% (+32.9%/yr)WST compounded faster over this window
80100120Start $1002026$83$133
MDLN WST

MDLN vs WST: by the numbers

  • MDLN is the larger company ($28.67B vs $24.83B market cap).
  • MDLN trades at the lower trailing earnings multiple (39.43 vs 45.11 P/E), one valuation lens rather than an overall verdict.
  • WST converts more revenue to profit (16.98% vs 2.31% net margin).
  • WST pays a dividend (0.25% yield), while MDLN has no payments in the available dividend history.

Metrics side by side

Valuation

MetricMDLNWST
P/E ratio39.4345.11
Forward P/E22.1639.45
P/S ratio0.987.56
P/B ratio2.528.41
EV / EBITDA14.3428.88
FCF yield6.94%1.74%

Profitability

MetricMDLNWST
Gross margin25.02%36.77%
Operating margin6.07%20.64%
Net margin2.31%16.98%
ROE5.97%18.89%
ROIC4.05%15.77%

Dividends

MetricMDLNWST
Dividend yieldN/A0.25%
Payout ratioN/A12.88%

Growth (annualized)

MetricMDLNWST
Revenue CAGR (5Y)N/A5.68%
EPS CAGR (5Y)N/A7.85%
FCF CAGR (5Y)N/A8.74%
Total return CAGR (5Y)N/A-4.37%

Frequently asked

Which has the lower trailing P/E, MDLN or WST?
MDLN has the lower trailing P/E: MDLN trades at 39.43 and WST at 45.11. P/E is one valuation measure and does not by itself establish which business is cheaper.
Does MDLN or WST pay a bigger dividend?
WST pays a dividend (0.25% yield), while MDLN has no payments in the available dividend history.
Is MDLN or WST more profitable?
WST runs the higher net margin — MDLN at 2.31% versus WST at 16.98%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 20, 2026.